Catalina Gaviria Agudelo

Dr. Catalina Gaviria Agudelo

WFIRM, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
CACatalina Gaviria Agudelo
Catalina Gaviria Agudelo
NBN.Y. Becerra
N.Y. Becerra
JVJ.D. Vergara
J.D. Vergara
LCL.A. Correa
L.A. Correa
SESergio Estrada
Sergio Estrada
LRLuz Marina Restrepo
Luz Marina Restrepo

18 June 2022 in Current Dermatology Reports
Verified
Journal Article
Closed access
PDF file
CACatalina Gaviria Agudelo
Catalina Gaviria Agudelo
LRLuz Marina Restrepo
Luz Marina Restrepo



Verified
Journal Article
Open access
PDF file
CACatalina Gaviria Agudelo
Catalina Gaviria Agudelo
LKLalitha M. Karchalla
Lalitha M. Karchalla
ZCZachary David Chandler
Zachary David Chandler
PMPatrick Michael McNutt
Patrick Michael McNutt
Human skin is a complex organ whose functions depend on coordinated interactions between the epidermal and stromal layers. Reproducing this architecture in vitro remains challenging, as existing human models reproduce a restricted subset of the structural and functional features inherent to native tissue. Here, we describe a fibrin-based, multicellular human skin equivalent (HSE) composed of primary human keratinocytes, fibroblasts, preadipocytes, and endothelial cells organized into epidermal and stromal compartments. The resulting constructs achieved mature epidermal stratification with appropriate phenotypic markers, developed robust barrier properties, underwent spontaneous endothelial network assembly, and exhibited transcriptional profiles consistent with native skin. Optimized culture conditions supported long-term structural and functional stability through 42 days, maintaining a proliferative basal cell layer and intact epidermal architecture. Non-destructive optical coherence tomography enabled longitudinal monitoring of epidermal growth, providing a practical method for real-time quality assessment. To evaluate their utility for disease modeling, HSEs were challenged with cowpox virus to model infection by a classic dermotropic virus. Infected HSEs reproduced classic epithelial pathologies of human orthopoxvirus infection and exhibited dose-dependent suppression of host interferon signaling pathways, recapitulating known viral immune-evasion mechanisms. Together, these findings establish the vascularized, adipose-integrated HSE as a platform for long-term studies of human skin biology, host–pathogen dynamics, and therapeutic development.

17 September 2025 in bioRxiv
Verified
Preprint
Open access
MRMaria F. Suarez Peredo Rodriguez
Maria F. Suarez Peredo Rodriguez
LJLaura J. Jilderda
Laura J. Jilderda
CACatalina Gaviria Agudelo
Catalina Gaviria Agudelo
JSJudith E. Simon
Judith E. Simon
AHAlexander M. Heberle
Alexander M. Heberle
FFFloris Foijer
Floris Foijer
Most cancers display chromosomal instability (CIN), a condition that leads to increased rates of chromosome missegregation and thus yields aneuploidy. CIN and aneuploidy are detrimental to healthy cells and therefore, aneuploid cells rely on aneuploidy-tolerating mechanisms to adopt a malignant fate. We previously found PRMT5 to be frequently amplified in a mouse model for aneuploid T cell lymphoblastic lymphoma. In this study, we investigated a possible role of PRMT5 as an aneuploidy tolerating gene. We report that PRMT5 is prone to aggregation when expressed at supra-stoichiometric levels compared to its obligate partner protein MEP50 (methylosome protein 50, WDR77). Intriguingly, we also find that protein aggregation, induced by CIN, is mitigated by jointly increased expression of PRMT5 and MEP50. Accordingly, concomitant PRMT5:MEP50 expression renders cancer cells less sensitive to proteasome inhibitors and CIN while inhibition sensitizes cells to CIN. Our findings provide a possible explanation for why PRMT5 and MEP50 display increased expression, particularly in aneuploid cancers and might reveal a targetable vulnerability of aneuploid cancer.